Skip to content
Screener
Agilent Technologies logo

Agilent Technologies

A

Agilent Technologies is a global leader in life sciences, diagnostics, and applied markets, providing comprehensive laboratory workflow solutions.

Market cap
$43.8B+29.9%
Revenue$7.4B+8.6%
Net income$1.4B+18.0%
Free cash flow$1.3B+16.5%
EPS (diluted)$5.07+18.7%
Trailing twelve months · change vs. prior year

Earnings

Next report

Nov 23, 2026 (in 3 months)
Revenue estimate$2.0B
EPS estimate$1.71

Financials

Q3 2026

Income statement

See full
Revenue$1.9B+8.1%
Gross profit$1.0B+17.3%
Operating income$444.0M+23.3%
Net income$362.0M+7.7%
EPS (diluted)$1.28+8.5%

Balance sheet

See full
Cash & equivalents$1.8B+14.4%
Total debt$3.9B+9.9%
Total equity$7.4B+15.6%
Total assets$14.0B+14.2%

Cash flow

See full
Operating cash flow$519.0M+43.4%
CapEx$80.0M-22.3%
Free cash flow$439.0M+69.5%

Valuation & ratios

Valuation

See full
Market cap$43.8B+29.9%
Enterprise value$45.99B+28.6%
P/E30.4×+2.8×
P/S5.9×+1.0×

Profitability

See full
Gross margin53.8%+1.2pp
Operating margin22.2%+1.0pp
Net margin19.5%+1.6pp
FCF margin17.2%+1.2pp

Returns & leverage

See full
Return on equity21%+1.1pp
Debt / equity0.5×0.0×
Current ratio2.1×-0.2×

Segments

By segment

See full
Life Sciences and Diagnostics Markets$746.0M+11.3%
Applied Markets$346.0M+6.8%

Competitors

Profile

Agilent Technologies is a global leader in life sciences, diagnostics, and applied markets, providing comprehensive laboratory workflow solutions. The company delivers a specialized portfolio of instruments, software, consumables, and services designed to help scientists and clinicians identify, quantify, and analyze biological and chemical properties. Their value proposition centers on application-focused solutions that span from basic research to clinical diagnostics and pharmaceutical manufacturing.

Competitive position

A leading global provider of laboratory workflow solutions with a dominant presence in chromatography and mass spectrometry.

GeographiesUnited States, China, Europe, Asia Pacific
Customer segmentsHealthcare Providers, Pharmaceutical & Biotech, Industrial & Applied Markets, Academic & Government
Business modelManufacturing, Contract Development and Manufacturing (CDMO), Professional Services, Consumables and Recurring Revenue
SuppliersElectronic component suppliers, Raw chemical and reagent providers, Specialized metal and glass manufacturers, Software developers
CustomersHospitals and Diagnostic Centers, Pharmaceutical R&D departments, Quality control laboratories, Environmental monitoring agencies
Listed1999
Employees17.6K
CEOPadraig McDonnell
FilingsSEC EDGAR

FAQ

What is Agilent Technologies's market cap?
Agilent Technologies (A) has a market capitalization of $43.8B and trades on NYSE.
What is Agilent Technologies's revenue and profitability?
Agilent Technologies generated $7.4B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 19.5%. Gross margin stands at 53.8%, with free cash flow of $1.3B. These figures are based on the Q3 2026 filing.
Who are Agilent Technologies's competitors?
Agilent Technologies's key competitors include Thermo Fisher Scientific, PerkinElmer, Danaher Corporation, and others. These companies compete in similar markets and product categories.
What subsidiaries does Agilent Technologies have?
Agilent Technologies's subsidiaries include BIOVECTRA.
Where is Agilent Technologies headquartered?
Agilent Technologies is headquartered in United States of America and employs approximately 17,600 people. It has been publicly traded since 1999.